Recent study revealed that ERBB2 promoted autophagy via upregulating the autophagy-related 12 (ATG12), which further induced resistance to ERBB2-targeted antibody lapatinib in breast cancer cells [21]. Here, ERBB2 is linked to breast carcinoma.